Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MAKO > SEC Filings for MAKO > Form 8-K on 8-Oct-2013All Recent SEC Filings

Show all filings for MAKO SURGICAL CORP.



Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equi

Item 2.01 Completion of Acquisition or Disposition of Assets.

As previously reported, on October 1, 2013, MAKO Surgical Corp. (the "Company") entered into an Asset Purchase Agreement (the "Purchase Agreement") with Pipeline Biomedical Holdings, Inc. ("Pipeline").

On October 8, 2013, pursuant to the terms of the Purchase Agreement, the Company completed the acquisition of substantially all of Pipeline's business dedicated to the design, development, manufacture and commercialization of orthopedic devices and related instruments for use with robotic devices and manual medical procedures (the "Transaction").

The purchase price for the Transaction consisted of a credit for a cash down payment previously paid to Pipeline in the amount of $2,500,000 and the Company's issuance at closing to Pipeline of an aggregate of 3,953,771 unregistered shares of common stock of the Company. The Company also entered into employment and consulting arrangements with certain key employees of the acquired business.

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the Purchase Agreement, which is filed as Exhibit 2.1 hereto and incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities.

The information set forth above in Item 2.01 regarding the unregistered sale of shares of common stock of the Company in connection with the Transaction is incorporated herein by reference.

Item 8.01 Other Events.

On October 8, 2013, the Company issued a press release announcing the closing of the Transaction. A copy of the press release is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(a) Audited and Unaudited Financial Statements of Businesses Acquired:

The Company will file any financial statements required by Item 9.01(a) by amendment not later than 71 calendar days after the date that this Current Report on Form 8-K is required to be filed.

(b) Pro Forma Financial Information:

The Company will furnish any pro forma financial information required by Item 9.01(b) by amendment not later than 71 calendar days after the date that this Current Report on Form 8-K is required to be filed.

(d) Exhibits:

Exhibit 2.1  Asset Purchase Agreement, dated October 1, 2013, by and between
             Pipeline Biomedical Holdings, Inc. and MAKO Surgical Corp.
             (incorporated by reference to Exhibit 2.1 to Form 8-K filed on
             October 2, 2013).†

Exhibit 99.1 Press Release dated October 8, 2013.

†Schedules and other similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules and attachments upon request by the U.S. Securities and Exchange Commission.

  Add MAKO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MAKO - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.